» Articles » PMID: 17431479

Skin Exposure to Isocyanates: Reasons for Concern

Overview
Date 2007 Apr 14
PMID 17431479
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Isocyanates (di- and poly-), important chemicals used worldwide to produce polyurethane products, are a leading cause of occupational asthma. Respiratory exposures have been reduced through improved hygiene controls and the use of less-volatile isocyanates. Yet isocyanate asthma continues to occur, not uncommonly in settings with minimal inhalation exposure but opportunity for skin exposure. In this review we evaluate the potential role of skin exposure in the development of isocyanate asthma.

Data Sources: We reviewed the published animal and human literature on isocyanate skin-exposure methods, workplace skin exposure, skin absorption, and the role of skin exposure in isocyanate sensitization and asthma.

Data Extraction: We selected relevant articles from computerized searches on Medline, U.S. Environmental Protection Agency, Occupational Safety and Health Administration, National Institute for Occupational Safety and Health, and Google databases using the keywords "isocyanate," "asthma," "skin," "sensitization," and other synonymous terms, and our own extensive collection of isocyanate publications.

Data Synthesis: Isocyanate production and use continues to increase as the polyurethane industry expands. There is substantial opportunity for isocyanate skin exposure in many work settings, but such exposure is challenging to quantify and continues to be underappreciated. Isocyanate skin exposure can occur at work, even with the use of personal protective equipment, and may also occur with consumer use of certain isocyanate products. In animals, isocyanate skin exposure is an efficient route to induce sensitization, with subsequent inhalation challenge resulting in asthma-like responses. Several lines of evidence support a similar role for human isocyanate skin exposure, namely, that such exposure occurs and can contribute to the development of isocyanate asthma in certain settings, presumably by inducing systemic sensitization.

Conclusions: Integrated animal and human research is needed to better understand the role of skin exposure in human isocyanate asthma and to improve diagnosis and prevention. In spite of substantial research needs, sufficient evidence already exists to justify greater emphasis on the potential risks of isocyanate skin exposure and the importance of preventing such exposures at work and during consumer use of certain isocyanate products.

Citing Articles

A Comprehensive Review of Occupational Medicine in the Paint Industry: Roles of Family Medicine and Internal Medicine.

Jogie J Cureus. 2025; 17(1):e76970.

PMID: 39912028 PMC: 11793994. DOI: 10.7759/cureus.76970.


Synthesis of polyurethanes through the oxidative decarboxylation of oxamic acids: a new gateway toward self-blown foams.

Jaussaud Q, Ogbu I, Pawar G, Grau E, Robert F, Vidil T Chem Sci. 2024; 15(33):13475-13485.

PMID: 39183929 PMC: 11339942. DOI: 10.1039/d4sc02562h.


Controlling Hybrid Polyhydroxyurethane Adhesive and Rheological Properties by Partial Carbonation of Biobased Epoxy Monomer.

Delliere P, Laborie D, Caillol S, Bakkali-Hassani C Macromol Rapid Commun. 2024; 45(23):e2400542.

PMID: 39073729 PMC: 11628358. DOI: 10.1002/marc.202400542.


Recycled Waste as Polyurethane Additives or Fillers: Mini-Review.

Peczek E, Pamula R, Bialowiec A Materials (Basel). 2024; 17(5).

PMID: 38473487 PMC: 10935100. DOI: 10.3390/ma17051013.


Study of Soybean Oil-Based Non-Isocyanate Polyurethane Films via a Solvent and Catalyst-Free Approach.

Patel P, de Souza F, Gupta R ACS Omega. 2024; 9(5):5862-5875.

PMID: 38343913 PMC: 10851237. DOI: 10.1021/acsomega.3c09185.


References
1.
Wilkinson S, Cartwright P, Armitage J, English J . Allergic contact dermatitis from 1,6-diisocyanatohexane in an anti-pill finish. Contact Dermatitis. 1991; 25(2):94-6. DOI: 10.1111/j.1600-0536.1991.tb01795.x. View

2.
Erjefalt I, Persson C . Increased sensitivity to toluene diisocyanate (TDI) in airways previously exposed to low doses of TDI. Clin Exp Allergy. 1992; 22(9):854-62. DOI: 10.1111/j.1365-2222.1992.tb02831.x. View

3.
Nemery B, Lenaerts L . Exposure to methylene diphenyl diisocyanate in coal mines. Lancet. 1993; 341(8840):318. DOI: 10.1016/0140-6736(93)92682-j. View

4.
Bernstein D, Korbee L, Stauder T, Bernstein J, Scinto J, Herd Z . The low prevalence of occupational asthma and antibody-dependent sensitization to diphenylmethane diisocyanate in a plant engineered for minimal exposure to diisocyanates. J Allergy Clin Immunol. 1993; 92(3):387-96. DOI: 10.1016/0091-6749(93)90117-x. View

5.
Streicher R, KENNEDY E, Lorberau C . Strategies for the simultaneous collection of vapours and aerosols with emphasis on isocyanate sampling. Analyst. 1994; 119(1):89-97. DOI: 10.1039/an9941900089. View